Clinical Laserthermia Systems AB (publ)
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control trea… Read more
Clinical Laserthermia Systems AB (publ) (CLS-B) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.161x
Based on the latest financial reports, Clinical Laserthermia Systems AB (publ) (CLS-B) has a cash flow conversion efficiency ratio of -0.161x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-10.69 Million) by net assets (Skr66.48 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Clinical Laserthermia Systems AB (publ) - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Clinical Laserthermia Systems AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Clinical Laserthermia Systems AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Clinical Laserthermia Systems AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wulandari Bangun Laksana
JK:BSBK
|
0.012x |
|
Grande Portage Resources Ltd
OTCQB:GPTRF
|
-0.008x |
|
Saga Pure ASA
OL:SAGA
|
0.004x |
|
Aguia Resources Ltd
AU:AGR
|
-0.045x |
|
SLCRF
OTCQX:SLCRF
|
N/A |
|
Intermedia Capital Tbk
JK:MDIA
|
0.031x |
|
TagMaster AB Series B
ST:TAGM-B
|
0.060x |
|
T2 Metals Corp.
V:TWO
|
-0.077x |
Annual Cash Flow Conversion Efficiency for Clinical Laserthermia Systems AB (publ) (2008–2025)
The table below shows the annual cash flow conversion efficiency of Clinical Laserthermia Systems AB (publ) from 2008 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr66.48 Million | Skr-33.20 Million | -0.499x | +41.89% |
| 2024-12-31 | Skr65.69 Million | Skr-56.45 Million | -0.859x | +43.70% |
| 2023-12-31 | Skr43.53 Million | Skr-66.45 Million | -1.527x | +83.01% |
| 2022-12-31 | Skr7.87 Million | Skr-70.69 Million | -8.988x | -187.72% |
| 2021-12-31 | Skr21.18 Million | Skr-66.17 Million | -3.124x | +21.47% |
| 2020-12-31 | Skr13.93 Million | Skr-55.41 Million | -3.978x | +28.85% |
| 2019-12-31 | Skr7.00 Million | Skr-39.12 Million | -5.591x | -619.15% |
| 2018-12-31 | Skr49.81 Million | Skr-38.72 Million | -0.777x | -5.20% |
| 2017-12-31 | Skr33.00 Million | Skr-24.39 Million | -0.739x | +35.74% |
| 2016-12-31 | Skr17.06 Million | Skr-19.63 Million | -1.150x | -19.85% |
| 2015-12-31 | Skr19.46 Million | Skr-18.68 Million | -0.960x | -92.50% |
| 2014-12-31 | Skr31.58 Million | Skr-15.74 Million | -0.499x | +28.93% |
| 2013-12-31 | Skr26.09 Million | Skr-18.30 Million | -0.702x | +0.45% |
| 2012-12-31 | Skr17.09 Million | Skr-12.05 Million | -0.705x | -28.07% |
| 2011-12-31 | Skr10.83 Million | Skr-5.96 Million | -0.550x | -15.89% |
| 2010-12-31 | Skr10.36 Million | Skr-4.92 Million | -0.475x | -38.16% |
| 2009-12-31 | Skr6.63 Million | Skr-2.28 Million | -0.344x | -1723.94% |
| 2008-12-31 | Skr3.68 Million | Skr-69.30K | -0.019x | -- |